Ac Immune Stock Buy Hold or Sell Recommendation
| ACIU Stock | USD 2.19 0.07 3.30% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding AC Immune is 'Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell AC Immune given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for AC Immune, the advice is generated through an automated system that utilizes algorithms and statistical models.Check out AC Immune Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy ACIU Stock please use our How to Invest in AC Immune guide. Note, we conduct extensive research on individual companies such as ACIU and provide practical buy, sell, or hold advice based on investors' constraints. AC Immune. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Execute AC Immune Buy or Sell Advice
The ACIU recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on AC Immune. Macroaxis does not own or have any residual interests in AC Immune or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute AC Immune's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | OK | Details | |
Volatility | Unstable | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
AC Immune Trading Alerts and Improvement Suggestions
| AC Immune appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 27.31 M. Net Loss for the year was (50.92 M) with loss before overhead, payroll, taxes, and interest of (35.02 M). | |
| AC Immune has a poor financial position based on the latest SEC disclosures | |
| About 38.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: AC Immune May Report Negative Earnings Know the Trend Ahead of Q2 Release |
AC Immune Returns Distribution Density
The distribution of AC Immune's historical returns is an attempt to chart the uncertainty of AC Immune's future price movements. The chart of the probability distribution of AC Immune daily returns describes the distribution of returns around its average expected value. We use AC Immune price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of AC Immune returns is essential to provide solid investment advice for AC Immune.
| Mean Return | 0.42 | Value At Risk | -5.26 | Potential Upside | 8.92 | Standard Deviation | 4.31 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of AC Immune historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
ACIU Stock Institutional Investors
The AC Immune's institutional investors refer to entities that pool money to purchase AC Immune's securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Handelsbanken Fonder Ab | 2025-03-31 | 130 K | Eversept Partners, Llc | 2025-03-31 | 100.8 K | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 72 K | Geode Capital Management, Llc | 2025-03-31 | 64.1 K | Banque Cantonale Vaudoise | 2025-03-31 | 26.7 K | Sei Investments Co | 2025-03-31 | 24.9 K | Two Sigma Advisers, Llc | 2025-03-31 | 23.6 K | Squarepoint Ops Llc | 2025-03-31 | 22.4 K | China Universal Asset Mgmt Co.ltd | 2025-03-31 | 19.8 K | Bvf Inc | 2025-03-31 | 19.8 M | Blackrock Inc | 2025-03-31 | 1.2 M |
AC Immune Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | (32.7M) | (78.7M) | (50.6M) | 46.9M | (42.2M) | (40.1M) | |
| Free Cash Flow | (61.2M) | (68.3M) | (74.8M) | (61.2M) | 65.3M | 68.5M | |
| Depreciation | 2.0M | 2.4M | 2.4M | 2.2M | 2.2M | 1.4M | |
| Other Non Cash Items | 551K | (6.2M) | (72K) | 2.4M | 1.6M | 1.7M | |
| Capital Expenditures | 1.7M | 2.6M | 1.2M | 801K | 576K | 547.2K | |
| Net Income | (61.9M) | (73.0M) | (70.8M) | (54.2M) | (50.9M) | (48.4M) | |
| End Period Cash Flow | 160.9M | 82.2M | 31.6M | 78.5M | 36.3M | 34.5M | |
| Change To Netincome | 2.4M | 5.0M | (1.9M) | 3.3M | 3.7M | 3.9M | |
| Investments | 30M | (53.7M) | 23.8M | 65.6M | (105.3M) | (100.0M) | |
| Net Borrowings | 50.1M | (946K) | 23.0M | (569K) | (654.4K) | (621.6K) |
AC Immune Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to AC Immune or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that AC Immune's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a ACIU stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.20 | |
β | Beta against Dow Jones | 2.03 | |
σ | Overall volatility | 4.39 | |
Ir | Information ratio | 0.07 |
AC Immune Volatility Alert
AC Immune shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure AC Immune's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact AC Immune's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.AC Immune Fundamentals Vs Peers
Comparing AC Immune's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze AC Immune's direct or indirect competition across all of the common fundamentals between AC Immune and the related equities. This way, we can detect undervalued stocks with similar characteristics as AC Immune or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of AC Immune's fundamental indicators could also be used in its relative valuation, which is a method of valuing AC Immune by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare AC Immune to competition |
| Fundamentals | AC Immune | Peer Average |
| Return On Equity | -0.43 | -0.31 |
| Return On Asset | -0.17 | -0.14 |
| Profit Margin | (1.84) % | (1.27) % |
| Operating Margin | (19.57) % | (5.51) % |
| Current Valuation | 40.75 M | 16.62 B |
| Shares Outstanding | 100.6 M | 571.82 M |
| Shares Owned By Insiders | 38.00 % | 10.09 % |
| Shares Owned By Institutions | 25.37 % | 39.21 % |
| Number Of Shares Shorted | 1.4 M | 4.71 M |
| Price To Earning | (16.96) X | 28.72 X |
| Price To Book | 1.83 X | 9.51 X |
| Price To Sales | 7.54 X | 11.42 X |
| Revenue | 27.31 M | 9.43 B |
| Gross Profit | (35.02 M) | 27.38 B |
| EBITDA | (48.62 M) | 3.9 B |
| Net Income | (50.92 M) | 570.98 M |
| Cash And Equivalents | 154.15 M | 2.7 B |
| Cash Per Share | 1.83 X | 5.01 X |
| Total Debt | 5.43 M | 5.32 B |
| Debt To Equity | 0.01 % | 48.70 % |
| Current Ratio | 13.28 X | 2.16 X |
| Book Value Per Share | 0.94 X | 1.93 K |
| Cash Flow From Operations | 65.84 M | 971.22 M |
| Short Ratio | 11.35 X | 4.00 X |
| Earnings Per Share | (0.64) X | 3.12 X |
| Target Price | 9.32 | |
| Number Of Employees | 133 | 18.84 K |
| Beta | 1.65 | -0.15 |
| Market Capitalization | 213.27 M | 19.03 B |
| Total Asset | 230.91 M | 29.47 B |
| Retained Earnings | (368.24 M) | 9.33 B |
| Working Capital | 71.16 M | 1.48 B |
| Current Asset | 160 M | 9.34 B |
AC Immune Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as ACIU . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About AC Immune Buy or Sell Advice
When is the right time to buy or sell AC Immune? Buying financial instruments such as ACIU Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having AC Immune in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Hotels Thematic Idea Now
Hotels
Hotels, inns, motels, and other companies providing lodging and hospitality services. The Hotels theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Hotels Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for ACIU Stock Analysis
When running AC Immune's price analysis, check to measure AC Immune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AC Immune is operating at the current time. Most of AC Immune's value examination focuses on studying past and present price action to predict the probability of AC Immune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AC Immune's price. Additionally, you may evaluate how the addition of AC Immune to your portfolios can decrease your overall portfolio volatility.